我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

安立生坦与波生坦对低氧性肺动脉高压大鼠右心室重构影响的比较研究

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第3期
页码:
257-261
栏目:
出版日期:
2013-06-25

文章信息/Info

Title:
Comparative study of effects of ambrisentan and bosentan on right ventricle remodeling in hypoxic pulmonary hypertension rats
作者:
徐 晶1; 张玉顺1; 宋 强1; 朱妙章2
(1.西安交通大学医学院第一附属医院心内二科，陕西 西安 710061；2.第四军医大学基础部生理学教研室，陕西 西安 710032)
Author(s):
XU Jing1;  ZHANG Yushun1;  SONG Qiang1;  ZHU Miaozhang2
(1.Second Department of Cardiology, First Affiliated Hospital, Medical College, Xi'an Jiaotong University, Xi’an 710061, Shaanxi, China; 2.Department of Physiology, School of Basic Medicine, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
低氧性肺动脉高压; 安立生坦; 波生坦; 心肌肥厚; 纤维化
Keywords:
hypoxic pulmonary hypertension;  ambrisentan;  bosentan;  hypertrophy;  myocardial fibrosis
分类号:
R543.2
DOI:
-
文献标识码:
A
摘要:
目的:比较安立生坦（ambrisentan）与波生坦（bosentan）对低氧性肺动脉高压大鼠（HPH）右心室重构的影响。方法：40只SD大鼠随机分成5组：正常对照组、模型组、安立生坦组、波生坦组、安慰剂组，每组8只。正常对照组于自然环境中饲养4周，其他组置于低压低氧舱中（8 h/d）饲养4周。从低氧开始第3周起，安立生坦组、波生坦组和安慰剂组大鼠每天进舱前依次分别给予安立生坦（5 mg/kg）、波生坦（125 mg/kg）及生理盐水（2 ml）灌胃，共两周。实验结束后，测定平均肺动脉压（mPAP）和右心室收缩压（RVSP）；计算右心室肥厚指数［RV/（LV+S）］及右心室质量/体质量（RW/BW）。右心室心肌以HE染色后，观察其形态学变化，以Masson染色后观察心肌胶原纤维容积分数（CVF）的变化。结果：与模型组和安慰剂组相比，安立生坦组和波生坦组的mPAP、RVSP、RV/(LV+S)、RW/BW、CVF值明显降低（P<0.05），安立生坦组和波生坦组相比，上述指标的差异无明显的统计学意义。HE染色切片显示，模型组和安慰剂组大鼠心肌细胞肥大，安立生坦组和波生坦组可基本恢复至正常组状态。结论：安立生坦与波生坦能显著降低HPH大鼠的肺动脉压力，抑制右心室肥厚及纤维化。安立生坦与波生坦相比，对HPH大鼠右心室重构的影响无明显差别。
Abstract:
AIM:To compare the effects of ambrisentan and bosentan on the right ventricle remodeling in hypoxic pulmonary hypertension (HPH) rats. METHODS: Forty Sprague Dawley rats were randomly divided into five groups: control group, model group, ambrisentan group, bosentan group and placebo group, with eight rats in each group. The rats in the control group were kept under normal environment for 4 weeks while the rats in the other groups were kept in hypobaric hypoxia environment (8 h/d) for 4 weeks. For bosentan group, ambrisentan group and placebo group, bosentan (125 mg/kg), ambrisentan (5 mg/kg) and normal saline (2 ml) were given at the third week, respectively. At the end of 4 weeks, the mean pulmonary arterial pressure (mPAP) and the right ventricular systolic pressure (RVSP) were determined, and RV/(LV+S) and the weight ratio of right ventricle weight vs. body weight (RW/BW) were calculated. The right ventricle tissues were stained in Masson to observe the degree of myocardial fibrosis and in HE to observe the pathological changes. RESULTS: Compared with those in the model group and the placebo group, mPAP, RVSP, RV/(LV+S), RW/BW and CVF in ambrisentan group and bosentan group significantly reduced, with no statistically significant difference in the observed indexes between ambrisentan group and bosentan group. HE staining revealed that the degree of myocardial hypertrophy significantly attenuated in ambrisentan group and bosentan group compared with that in model group and placebo group. CONCLUSION: Ambrisentan and bosentan effectively decreases pulmonary artery pressure and restrains right ventricular hypertrophy and myocardial fibrosis in HPH rats. There is no significant difference in the effects of ambrisentan and bosentan on the right ventricle remodeling in HPH rats.

参考文献/References

[1]Bogaard HJ,Abe K,Vonk Noordegraaf A,et al.The right ventricle under pressure:Cellular and molecular mechanisms of rightheart failure in pulmonary hypertension[J].Chest,2009,135(3):794-804.
[2]Benza RL,Raybum BK,Tallaj JA,et al.Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease[J].Chest Apr,2006,129(4):1009-10015.
[3]王佳兴,张玉顺,刘海莲,等.波生坦对实验性高原性肺动脉高压的逆转作用[J].心脏杂志,2009,21(4):488-492.
[4]刘海莲,张玉顺,王佳兴,等.波生坦对慢性低氧性肺动脉高压大鼠右心室肥厚及缝隙连接蛋白(Cx)43表达的影响[J].心脏杂志,2010,22(1):51-55.
[5]Pei JM,Sun X,Guo HT,et al.U50,488 H Depresses pulmonary pressure in rat subjected to chronic hypoxia[J].J Cardiovasc Pharmacol,2006,47(4):594-598.
[6]Van Dan Borne SW,Diez J,Blankesteijn WM,et al.Myocardial remodeling after infarction: the role of myfibroblast[J].Nat Rev Cardiol,2010,7(1):30-37.
[7]陈莉延,麦 奇,彭 勃,等.白藜芦醇苷对慢性常压低氧性 PH模型中磷脂酶A-2、一氧化氮和内皮素水平的影响[J].中国病理生理杂志,2006,22(5):953-955.
[8]Pullamsetti SS,Schermuly RT.Endothelin receptor antagonists in preclinical models of pulmonary hypertension[J].Eur J Clin Invest,2009,39(Suppl 2):38-49.
[9]Hafizi S,Wharton J,Cheste AH,et al.Profibrotic effects of endothelin1 via the ETA receptor in cultured human cardiac fibroblasts[J].Cell Physiol Biochem, 2004,14(4-6):285-292.
[10]You HW,Chen X,You HJ,et al.Role of endothelin1 and its receptors on hypertrophy or proliferation of cultured cardial cells[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2006,28(4):520-523.
[11]李 娟,孙 新,毕 辉,等.低压低氧性大鼠肺动脉高压模型的建立[J].临床心血管病杂志,2008,24(4):297-301.
[12]Jacobs A,Preston IR,Gomberg Maltland M.Endothelin receptor antagonism in pulmonary arterial hypertension a role for selective ETA inhibition[J].Curr Med Res Opin,2006,22(12):2567-2574.
[13]Feger GI,Schilling L,Ehrenreich H, et al. Endotheliumdependent relaxation counteracting the contractile action of endothelin1 is partly due to ETB receptor activation[J].Res Exp Med(Berl),1997,196(1):327-337.
[14]刘文芳，傅德兴，胡欣.治疗肺动脉高压新药安贝生坦的药理与临床研究[J].中国新药杂志,2008,17(23):2070-2073.

备注/Memo

备注/Memo:
收稿日期：2013-03-07.
通讯作者：张玉顺，主任医师，主要从事先天性心脏病介入治疗研究Email:zys2889@sina.com
作者简介：徐晶，硕士生Email:xujing871008@163.com
更新日期/Last Update: 2013-07-16